4.8 Review

NOD2 and Crohn's disease: Loss or gain of function?

Journal

IMMUNITY
Volume 22, Issue 6, Pages 661-667

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2005.06.004

Keywords

-

Categories

Funding

  1. NCRR NIH HHS [RR17030] Funding Source: Medline
  2. NIAID NIH HHS [AI61712] Funding Source: Medline
  3. NIDDK NIH HHS [DK35108] Funding Source: Medline

Ask authors/readers for more resources

The human nucleotide binding and oligomerization domain (NOD)-containing protein family consists of some 25 members related to the Apaf-1/Ced-4 family of apoptosis regulators and certain plant disease-resistance genes (Inohara et al., 2004). One member, NOD2 (CARD15), has gained recent prominence through its association with increased susceptibility to several clinically important human inflammatory diseases, especially Crohn's disease (CD). NOD2 is a cytoplasmic molecule involved in sensing microbial cell wall components and regulating inflammatory processes and apoptosis. This review focuses on recent insights into the functions of normal and variant NOD2 proteins and the pathogenetic mechanisms underlying NOD2-associated inflammatory diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available